用构建的新型BmNPV载体在家蚕高效表达人β-干扰素

构建了家蚕核多角体病毒(Bombyx mori nuclear polyhedrosis virus,BmNPV)新型载体pBm92,该载体将多角体蛋白基因的起始密码ATG改变为ATT,然后在多角体蛋白基因的+12位后连接有5个外源基因的克隆位点。将HulFN-β基因克隆在多角体蛋白基因的+12位后,构建了pBmIFN+12;同时构建了HuIFN－β克隆在－3位后的转移载体pB．mIFN－3。将两种转移载体DNA分别与BmNPV基因组DNA共转染Bm—N细胞。利用重组病毒不产生多角体蛋白的特征,筛选重组病毒。用HuIFN－β基因探针与重组病毒DNA进行杂交鉴定。重组病毒BmIFN+12感染Bm-N细胞,其上清IFN活性为2．0×10⁶Iu／ml,将BmIFN+12注射5龄家蚕虫体,表达水平为5．O×10⁷Iu／ml,是HulFN-β基因克隆在多角体蛋白基因的-3位后获得的重组病毒表达量的2—4倍。构建的新型BmNPv载体能够在家蚕高效地表达HuIFN-β。家蚕虫体生产的rHulFN-β蛋白具有天然HuIFN-β的抗原性。     

金鱼生长激素II基因在杆状病毒中的表达

以ｐＳＸＩＶＶＩ＾＋Ｘ３为转移载体,将编码金鱼生长激素Ⅱ的ｃＤＮＡ插入粉纹夜蛾核型多角体病毒（ＴｎＮＰＶ）基因组中,构建了重组病毒株ＴｎＮＰＶ－ＳＸ＾＋ｇｆＧＨⅡ４６。该毒株能在草地贪夜蛾离体培养细胞及银纹夜蛾幼虫中表达金鱼生长激素基因。蛋白免疫印迹表明,表达的生长激素蛋白分子量为２２．５ｋＤａ,与理论计算值相符,且表达的生长激素可分泌到感染细胞的培养基及虫体血淋巴中。ＲＩＡ结果表明,表达产物与天     

金鱼生长激素Ⅱ基因在杆状病毒中的表达

以ｐＳＸＩＶＶＩ＋Ｘ３为转移载体,将编码金鱼生长激素Ⅱ的ｃＤＮＡ插入粉纹夜蛾核型多角体病毒（ＴｎＮＰＶ）基因组中,构建了重组病毒株ＴｎＮＰＶＳＸ＋ｇｆＧＨⅡ４６。该毒株能在草地贪夜蛾（Ｓｐｏｄｏｐｔｅｒａｆｒｕｇｉｐｅｒｄａ）离体培养细胞及银纹夜蛾（Ａｇｙｒｏｇｒａｍｍａａｇｎａｔａ）幼虫中表达金鱼生长激素基因。蛋白免疫印迹表明,表达的生长激素蛋白分子量为２２．５ｋＤａ,与理论计算值相符,且表达的生长激素可分泌到感染细胞的培养基及虫体血淋巴中。ＲＩＡ结果表明,表达产物与天然的生长激素有相似的免疫特性,重组病毒在感染细胞９６ｈｐｉ所表达的生长激素达到最高水平,平均每１０５个细胞可在细胞培养基中检测到金鱼生长激素Ⅱ达８６．７４ｎｇ;平均每克干虫可产生金鱼生长激素Ⅱ２１４μｇ。     

杆状病毒转移载体的构建及绿色荧光蛋白在斜纹夜蛾幼虫中的表达

为构建斜纹夜蛾核型多角体病毒 （SpltMNPV）的重组病毒,以该病毒日本C3株基因组DNA为PCR扩增模板,根据GenBank SpltMNPV中国G2株基因序列,设计了两对引物分别扩增多角体蛋白基因的5′端侧翼序列（含启动子）和3′端侧翼序列（含终止子）,将这两个片段依次克隆于pUC18质粒载体后,再将绿色荧光蛋白(GFP)基因亚克隆到上述载体的多角体蛋白基因启动子和终止子之间,获得转移载体pSplt-gfp。将pSplt-gfp与野生型SpltMNPV 基因组DNA共转染Spli细胞,通过同源重组和有限稀释法筛选,获得了以gfp基因替代多角体蛋白基因的重组病毒SpltMNPV-gfp。SpltMNPV-gfp感染Spli细胞和斜纹夜蛾幼虫,分别在感染24h和48h后可发现绿色荧光蛋白的表达。该重组病毒的获得,为建立斜纹夜蛾核型多角体病毒表达体系奠定了基础。     

利用杆状病毒载体在棉铃虫血细胞中表达大肠杆菌β－半乳糖苷酶

用携带大肠杆菌β－半乳糖苷酶基因的杆状病毒转移载体pAc36O－B－gal与野生型的苜蓿丫纹夜蛾(AcNPV)DNA同时转染草地夜蛾细胞,经x—gal筛选和空斑纯化得到重组型杆状病毒AcNPV－β－gal。该重组病毒能有效地感染棉铃虫血细胞系,并高效表达出受AcNPV多角体蛋白启动子控制的、具有生物活性的外源基因产物－－β－半裂糖苷酶。80％以上的酶蛋白能分泌到细胞外,培养液中酶活可达每毫升50000单位以上,约相当于170μg酶蛋白。用要SDS－聚丙烯酰胺凝胶电泳分离表达产物和β－半乳糖苷酶在凝胶上的特异性显色反应分析,重组病毒在棉铃虫血细胞中表达的AcNPV多角体蛋白－－大肠杆菌β－半乳糖苷酶融合蛋白是以5种活性的多聚体或复合物形式存在的。     

双基因双重组AcNPV的构建及其杀虫活性

质粒pAcIEneo携带杆状病毒极早期基因IE1启动子驱动的新霉素抗性基因(neo),经酶切回收后插入到质粒pAc34DZ1的SacI位点上,构建成多角体外膜蛋白基因(pe)失活的转移载体pAc34DZ2。我们曾构建了一个多角体完整(ocu+)的表达苏云金杆菌(Bt)截短cryIab基因的重组病毒(1)vAcPhBtT。为了改进这一重组病毒的杀虫效率,将转移载体pAc34DZ2与重组病毒(1)vAcPhBtT DNA共转染Sf9细胞,进行第二次同源重组。由于neo基因的表达,用G418筛选得到重组病毒(2)vAcPhBtTPE^-;Southern blot证明vAcPhBtTPE-的构建是正确的,经SDS-PAGE分析,重组病毒(2)仍然能在昆虫细胞中表达80kD的Bt截短毒蛋白,但不表达34kD的多角体外膜蛋白。电镜观察重组病毒(2)无多角体外膜,碱解时病毒粒子释放的速度快于重组病毒(1)。以重组病毒(2)感染甜菜夜蛾三龄幼虫,LC₅₀比野生型病毒小了接近1倍,LT₅₀提前近2d。     

人α型肿瘤坏死因子基因在昆虫细胞中的表达

将人肿瘤坏死因子α(Tumoor Necrosis Factor α,TNF-α)cDNA片段克隆到转移载体pat610上．然后与苜蓿尺蠖核型多角体病毒(Autogropha californica Nuclear PolyhedrinVirus,AcNPV)DNA共转染草地贪夜蛾细胞(Sptodoplet frugiperda)Sf21,获得含hTNF-a基因的重组病毒。以L929细胞毒方法测得重组病毒感染Sf21细胞72小时时的表达量最高,为1．0×10^-4u／lO 6细胞;同时,培养液中小牛血清浓度对hTNF－α表达量有较大影响,当浓度为6%时hTNF—α表达量最高．感染72小时表达量可达5．2×10⁴u／1O⁶细胞,ELISA实验结果证明其产物确为hTNF—α。     

表达昆虫特异性神经麻痹毒素AaIT的杀虫杆状病毒的构建

根据杆状病毒核多角体基因及植物基因的密码子选择偏向、G+C含量和密码子第三位碱基的G+C含量,同时综合在真核系统中影响基因转录、翻译及影响mRNA稳定性等因素,在不改变所编码的氨基酸序列的基础上,设计并人工合成了昆虫特异性神经蝎毒素AaIT基因。合成的AaIT基因与合成的gp67信号肽DNA序列正确融合后通过杆状病毒转移载体pSXIV VI⁺X3体内重组到粉纹夜蛾多角体病毒(Trichoplusia ni nuclear polyhedrosis virus,TnNPV)上,得到重组病毒TnNPV-AaIT。经Southern blotting验证了AaIT基因整合在TnNPV基因组中,SDS-PAGE证明AaIT基因在重组病毒中的表达。通过用重组病毒口服感染供试昆虫,证明了含AaIT基因的重组病毒能显著缩短杆状病毒的杀虫时间,提高杀虫效率。这是迄今为止我国构建的第一株具有实用价值和应用前景的基因工程病毒。     

棉铃虫颗粒体病毒增效蛋白基因2.1kb片段在大肠杆菌中的表达

以棉铃虫颗粒体病毒(Helicoverpa armigera granulosis virus,简称HaGV)基因组DNA为模板,设计引物PCR扩增病毒增效蛋白(Enhancin)基因,然后经SacI/PstI双酶切消化,得到5′端截短的约2.1kb增效蛋白基因片段,再与pQE30质粒连接,构建了重组表达载体pQE/EnC,转化大肠杆菌M15(pREP4),在IPTG诱导下表达出分子量约为78×10³ D的融合蛋白并命名为P78,纯化的P78包涵体显示了明显的增效活性,可提高AcMNPV对小菜蛾幼虫的感染率27.88%～32.92%。     

SARS冠状病毒核衣壳蛋白在酵母中的表达与活性检测

用PCR扩增SARS冠状病毒N蛋白全长cDNA,克隆到酵母表达载体pPIC3.5K,构建pPIC3.5K-SCoVN酵母表达质粒。表达质粒线性化后电转化到毕赤酵母GS115中,经G418-RDB, MM/MD平板与PCR扩增筛选获得His⁺ Mut⁺ 重组菌株。比较研究了不同的培养基、溶解氧以及甲醇浓度对菌株生长与重组蛋白表达的影响。结果表明：FBS培养基最适宜重组菌的生长与表达,溶氧对菌体的生长与表达有显著的影响,甲醇诱导最佳终浓度为1％（V/V）,SDS-PAGE分析重组蛋白的表达量,发现重组N 蛋白表达量占细胞总蛋白的6％,每升培养基可以生产410mg重组N蛋白,生物量达45OD600。Western　blotting结果表明,重组N 蛋白对鼠源单克隆抗体以及SARS病人恢复期血清具有较强的特异性反应。对摇瓶培养条件进行了发酵罐放大实验,结果生物量达到348OD600,表达量达到 2.5g/L,分别为摇瓶表达的7.7倍和6.1倍,为SARS早期血清学诊断研究以及为N蛋白在病毒复制以及致病机理的研究奠定了一定的基础。     

Expression of a subgenomic retroviral messenger RNA

When mRNA for avian retroviral envelope glycoprotein (env) was injected into cells transformed by env-deficient Bryan Rous sarcoma virus, the env deficiency of the injected cells was complemented to allow the release of transforming virus for up to 40 hr. When virus spread within the injected culture was allowed to occur, a second phase of transforming virus production by the injected culture began approximately 2 days following injection, continued for many days and often increased to titers well above those seen soon after injection. The requirement for virus spread, along with the genetic properties of virus released long after injection, supported the hypothesis that the second phase of virus production resulted when injected env mRNA was packaged into virus released by injected cells. When this virus infected other cells within the culture the env mRNA was reverse-transcribed to form a subgenomic, proviral-like molecule able to direct the synthesis of env mRNA. Accordingly, it was shown that neither DNA nor full genomic viral RNA contaminating injected mRNA preparations could account for the results. Evidence that an mRNA can be reverse-transcribed into an active, proviral-like molecule may be of importance in the relationship between retroviruses and their hosts.     

Expression of lymphotoxin gene inserted into Theiler's murine encephalomyelitis virus

Theiler's murine encephalomyelitis virus (TMEV) belongs to the Picornaviridae genus. DA subgroup strains of this virus induce early, non-fatal polioencephalomyelitis followed by demyelination in the spinal cord, with virus persistence. We investigated the use of DA strain as a vector for the introduction of a foreign gene into the central nervous system. Human lymphotoxin (LT) gene was inserted in the L region, the most upstream part of the polyprotein coding region of DA genome. Expression of LT was demonstrated by an immunoblot and an enzyme-linked immunosorbent assay on BHK-21 cells that were infected with the recombinant virus. In addition, the expressed LT showed cytotoxicity against L-929 cells.     

Expression of baboon endogenous virus in exogenously infected baboon cells.

Strains of low-passage, fetal diploid, baboon (Papio cynocephalus) fibroblasts were susceptible to exogenous infection with three independent isolates of baboon endogenous virus, as measured by an immunofluorescence assay specific for viral p28. Infectivity of the M7 strain of baboon endogenous virus for baboon cells of fetal skin muscle origin was equivalent to that for human and dog cells in that similar, linear, single-hit titration patterns were obtained. The assay for supernatant RNA-dependent DNA polymerase, however, showed that baboon cells produced only low levels of virus after infection compared with the production by heterologous cells. The results showed that baboon endogenous virus was capable of penetrating baboon cells and that viral genes were expressed in infected cells. Replication of complete infectious virus was restricted, however, indicating that in this primate system homologous cells differentially regulated the expression of viral genes.     

Expression of a foreign protein by influenza A virus.

In this report we describe the rescue of a transfectant influenza A virus which stably expresses a heterologous protein, bacterial chloramphenicol acetyltransferase (CAT). The foreign sequences encoding CAT are expressed as part of an essential influenza virus segment, that coding for the neuraminidase (NA) protein. The novel way by which this was achieved involved inserting in frame the 16-amino-acid self-cleaving 2A protease of foot-and-mouth disease virus between the CAT and the NA coding sequences. The resultant gene produces a polyprotein which is proteolytically cleaved to release both CAT and NA. The intramolecular cleavage occurs at the C terminus of the 2A sequence between a glycine-proline dipeptide motif such that the released NA protein has an additional N-terminal proline residue. The transfectant virus is stable upon passage in tissue culture. CAT activity is expressed at high levels in cell culture supernatants and in the allantoic fluid of infected eggs. Since the chimeric segment must maintain the heterologous reading frame to retain viability, the virus stability is dependent upon concomitant synthesis of the heterologous protein. This design may be particularly appropriate for utilization of influenza virus as a mammalian expression vector.     

Improved Transient Protein Expression by pFluNS1 Plasmid

Influenza virus nonstructural protein-1 (NS1) is abundantly expressed in influenza virus infected cells. NS1 is well recognized for counteracting host antiviral activities and regulating host and viral protein expression. When used as a plasmid component in DNA transfection, NS1 was shown to significantly increase expression levels of a cotransfected gene of different plasmid. Our previous studies demonstrated that addition of an NS1 plasmid increased the expression levels of influenza virus secreted neuraminidase (sNA) gene in 293T cells. In this study, we improved the utilization of NS1 as an enhancer for transient protein expression by generating pFluNS1 plasmid to contain two expression cassettes; one encoding an NS1 gene and another encoding a gene of interest. pFluNS1 is expected to codeliver the NS1 gene into the same cells receiving the gene of interest. The plasmid is therefore designed to induce higher protein expression levels than a cotransfection of an NS1 plasmid and a plasmid containing a gene of interest. To test the efficiency of pFluNS1, influenza virus sNA and non-viral DsRed genes were cloned into pFluNS1. The expression of these genes from pFluNS1 was then compared to the expression from a cotransfection of an NS1 plasmid and an expression plasmid coding for sNA or DsRed. We found that gene expression from pFluNS1 reached equal or higher levels to those derived from the cotransfection. Because the expression from pFluNS1 needs only one plasmid, a lesser amount of transfection reagent was required. Thus, the use of pFluNS1 provides a transfection approach that reduces the cost of protein expression without compromising high levels of protein expression. Together, these data suggest that pFluNS1 can serve as a novel alternative for an efficient transient protein expression in mammalian cells.     

仙台病毒核衣壳蛋白基因的克隆与原核表达

目的利用原核表达系统表达仙台病毒(Sendai Virus,SV)核衣壳蛋白。方法根据GenBank上发表的仙台病毒(Sendai Virus,SV)核衣壳蛋白基因序列,设计并合成一对引物,通过RT-PCR扩增出核衣壳蛋白全长cDNA序列,将其克隆至原核表达载体pET-30a,转化大肠杆菌BL21(DE3)PlysS,于37℃1mmol/LIPTG条件下诱导表达,大肠杆菌裂解物经SDS-PAGE分析,在相对分子质量约60×103处出现一新蛋白带,与预期目的蛋白分子量相符。结果Western blot检测表明,表达产物能与兔抗SV阳性血清发生特异性反应,出现单一反应带,表明其具有免疫原性。结论为建立以重组NP蛋白为诊断抗原检测SV奠定基础。     

Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals

Classical antiviral therapies target viral proteins and are consequently subject to resistance. To counteract this limitation, alternative strategies have been developed that target cellular factors. We hypothesized that such an approach could also be useful to identify broad-spectrum antivirals. The influenza A virus was used as a model for its viral diversity and because of the need to develop therapies against unpredictable viruses as recently underlined by the H1N1 pandemic. We proposed to identify a gene-expression signature associated with infection by different influenza A virus subtypes which would allow the identification of potential antiviral drugs with a broad anti-influenza spectrum of activity. We analyzed the cellular gene expression response to infection with five different human and avian influenza A virus strains and identified 300 genes as differentially expressed between infected and non-infected samples. The most 20 dysregulated genes were used to screen the connectivity map, a database of drug-associated gene expression profiles. Candidate antivirals were then identified by their inverse correlation to the query signature. We hypothesized that such molecules would induce an unfavorable cellular environment for influenza virus replication. Eight potential antivirals including ribavirin were identified and their effects were tested in vitro on five influenza A strains. Six of the molecules inhibited influenza viral growth. The new pandemic H1N1 virus, which was not used to define the gene expression signature of infection, was inhibited by five out of the eight identified molecules, demonstrating that this strategy could contribute to identifying new broad anti-influenza agents acting on cellular gene expression. The identified infection signature genes, the expression of which are modified upon infection, could encode cellular proteins involved in the viral life cycle. This is the first study showing that gene expression-based screening can be used to identify antivirals. Such an approach could accelerate drug discovery and be extended to other pathogens.     

Expression and characterization of bovine lactoperoxidase by recombinant vaccinia virus

Lactoperoxidase (LPO) is a 78 kDa heme-containing oxidation–reduction enzyme present in milk, found in physiological fluids of mammals. LPO has an antimicrobial activity, and presumably contribute to the protective functions of milk against infectious diseases. In this study, recombinant vaccinia virus expressing bovine LPO (vv/bLPO) was constructed. In rabbit kidney (RK13) cells infected with vv/bLPO, recombinant bLPO was detected in both cell extracts and culture supernatants. Tunicamycin treatment decreased the molecular weight of recombinant bLPO, indicating that recombinant bLPO contains a N-linked glycosylation site. The replication of recombinant vaccinia viruses expressing bovine lactoferrin (vv/bLF) at a multiplicity of infection (moi) of 5 plaque-forming units (PFU)/cell was inhibited by antiviral activity of recombinant bLF, suggesting that vv/bLF has an antiviral effect against vaccinia virus. On the other hand, the replication of vv/bLPO at a moi of 5 PFU/cell was not inhibited by antiviral activity of recombinant bLPO, indicating that this recombinant virus could be used as a suitable viral vector. These results indicate that a combination of bLPO and vaccinia virus vector may be useful for medical and veterinary applications in vivo.     

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Norwalk virus capsid protein was produced by expression of the second and third open reading frames of the Norwalk virus genome, using a cell-free translation system and baculovirus recombinants. Analysis of the expressed products showed that the second open reading frame encodes a protein with an apparent molecular weight of 58,000 (58K protein) and that this protein self-assembles to form empty viruslike particles similar to native capsids in size and appearance. The antigenicity of these particles was demonstrated by immunoprecipitation and enzyme-linked immunosorbent assays of paired serum samples from volunteers who developed illness following Norwalk virus challenge. These particles also induced high levels of Norwalk virus-specific serum antibody in laboratory animals following parenteral inoculation. A minor 34K protein was also found in infected insect cells. Amino acid sequence analysis of the N terminus of the 34K protein indicated that the 34K protein was a cleavage product of the 58K protein. The availability of large amounts of recombinant Norwalk virus particles will allow the development of rapid, sensitive, and reliable tests for the diagnosis of Norwalk virus infection as well as the implementation of structural studies.     

Expression of complete chicken thymidine kinase gene inserted in a retrovirus vector.

The chicken thymidine kinase (tk) gene was inserted into spleen necrosis virus. Thymidine kinase activity was expressed even when the promoter and terminator sequences for tk RNA synthesis were retained. When the promoter was present in the same orientation as the promoter in the long terminal repeat of the virus, deletions occurred both in the virus and in the tk gene, and the thymidine kinase-transforming activity of the recovered virus was low. Splicing of apparent intervening sequences in the tk gene was also observed. When the orientation of the tk promoter was opposite to the promoter in the long terminal repeat, virus synthesis was diminished, whereas thymidine kinase activity was expressed at an elevated level compared with virus in which the promoter was in the same orientation. However, when the apparent tk promoter was deleted from virus with the tk gene in the opposite orientation, a high level of virus synthesis was observed, probably as a result of absence of interference of RNA synthesis from converging promoters. The intervening sequences in the virus in which the promoters were in opposite orientation were not spliced.